Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNERGY: Solifenacin + Mirabegron in OAB
NCT01972841Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2013
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 42
01
Overview
A Phase 3 trial of solifenacin, mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Nov 2013; status: completed.
02
Drugs
solifenacinmirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01972841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972841.